HIV News and Research

RSS

Remdesivir drug stops novel coronavirus from replicating

Scientists from the University of Alberta have published findings that the antiviral drug remdesivir prevents replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by inhibiting RNA replication. The study, published in April 2020 in the Journal of Biological Chemistry, follows on the heels of earlier reports from the same lab in February, showing the drug's effectiveness against the related Middle East Respiratory Syndrome (MERS) virus.

15 Apr 2020

Health agencies urge continuation of life-saving measles vaccinations

The novel coronavirus disease, now officially called COVID-19, threatens the vaccination of millions of children across the globe. With most countries in lockdown and health care workers overwhelmed, many vaccination schedules have been delayed, threatening the welfare of infants and children.

15 Apr 2020

Ebola drug effective against key enzyme of coronavirus that causes COVID-19

Scientists at the University of Alberta have shown that the drug remdesivir is highly effective in stopping the replication mechanism of the coronavirus that causes COVID-19, according to new research published today in the Journal of Biological Chemistry.

13 Apr 2020

How does COVID-19 attack the body?

The coronavirus disease (COVID-19) attacks the lungs, leading to pneumonia, and eventually, a cascade of serious complications. But how does COVID-19 kill? Is it the virus itself or the result of the person’s immune system response?

13 Apr 2020

Novel coronavirus attacks and destroys T cells, just like HIV

The immune system has many components that work together in protecting the body from foreign invaders. One of the most important types of immune cells is T lymphocytes or T cells, a type of white blood cell that acts as the core of adaptive immunity, the system that modifies the immune response to specific pathogens.

13 Apr 2020

Cost of ‘repurposing’ existing drugs to treat COVID-19

The paper looks at repurposed drugs that might demonstrate efficacy against COVID-19, and if they could be manufactured profitably at very low costs to ensure affordable access to vital treatments for COVID-19 at low prices globally.

13 Apr 2020

Rockefeller and SNF announce $3 million expansion of partnership for COVID-19 research

The Rockefeller University and the Stavros Niarchos Foundation today announced a $3 million expansion of their longstanding partnership for research and medicine, bolstering Rockefeller's round-the-clock research initiatives related to COVID-19 and the SARS-CoV-2 virus that causes it.

13 Apr 2020

Arizona COVID-19 Genomics Union to study how the virus may be evolving

The Translational Genomics Research Institute, an affiliate of City of Hope, The Pathogen and Microbiome Institute at Northern Arizona University, and the Department of Ecology and Evolutionary Biology at the University of Arizona have formed a union dedicated to tracking the COVID-19 coronavirus, it was announced today.

10 Apr 2020

Top NAU microbiologist joins Arizona COVID-19 Genomics Union

The Translational Genomics Research Institute, an affiliate of City of Hope, The Pathogen and Microbiome Institute at Northern Arizona University and the Ecology and Evolutionary Biology Department at the University of Arizona have formed a union dedicated to tracking the COVID-19 coronavirus, it was announced today.

8 Apr 2020

Benefits of marijuana for pain relief are not clear-cut, study suggests

Medical marijuana users who say they have high levels of pain are more likely than those with low pain to say they use cannabis three or more times a day, a new study finds.

8 Apr 2020

Philadelphia Eagles owner contributes $1 million to Penn Medicine to fight COVID-19 pandemic

Philadelphia Eagles owner Jeffrey Lurie today announced a $1 million contribution to Penn Medicine to establish the COVID-19 Immunology Defense Fund, laying the foundation for the world's foremost experts to fight the novel coronavirus pandemic.

8 Apr 2020

Infectious diseases from animals likely to cause further pandemics

As humans move to cities to settle, there is a sharp decline in biodiversity leading to several disturbances in the balance and relationship between humans and wild animals. A new study from researchers at the University of California, Davis' One Health Institute, shows that this has led to the spread of zoonotic viruses from animals to humans, such as COVID-19, which has caused a global pandemic involving over 184 countries and territories. The study was published in the latest issue of Proceedings of the Royal Society B.

8 Apr 2020

Study reveals the coronavirus camouflage that will aid vaccine design

Research led by the University of Southampton has revealed the fundamental features of the SARS-CoV-2 coronavirus that causes COVID19.

8 Apr 2020

Exploring mechanisms of resistance to HIV in people with sickle cell disease

Analysis supports reports that sickle cell disease causes lower HIV infection rate, but cell studies did not reveal a mechanism.

8 Apr 2020

Study shows how forest loss puts people at greater risk of infectious diseases

Viruses that jump from animals to people, like the one responsible for COVID-19, will likely become more common as people continue to transform natural habitats into agricultural land, according to a new Stanford study.

7 Apr 2020

Depressive disorders in patients with HIV/AIDS often go unrecognized or untreated

People living with HIV/AIDS are at increased risk of depressive disorders. But all too often, these conditions go unrecognized or untreated, suggests a literature review in the May/June issue of Harvard Review of Psychiatry.

7 Apr 2020

How do viruses mutate and jump to humans?

Zoonotic spillover events like the current novel coronavirus pandemic present threats to human health. But what is zoonotic spillover and how do they occur?

7 Apr 2020

Research reveals a potential 'chink in the armor' of SARS-CoV-2

The scientists from Scripps Research, reveal a likely vulnerability or weakness of the coronavirus. An antibody, called CR3022, recovered from a survivor of the SARS outbreak in 2002, has shown a potential vulnerability of the novel coronavirus.

6 Apr 2020

Antiparasitic drug Ivermectin kills coronavirus in 48 hours

Around the world, scientists race to develop a vaccine or treatment against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, a team of researchers has found that a drug already available around the world can kill the coronavirus in a lab setting in just 48 hours.

6 Apr 2020

Antibody recovered from SARS survivor reveals potential vulnerability of new coronavirus

An antibody recovered from a survivor of the SARS epidemic in the early 2000s has revealed a potential vulnerability of the new coronavirus at the root of COVID-19, according to a study from scientists at Scripps Research.

3 Apr 2020